← Back to Clinical Trials
Recruiting NCT06209853

NCT06209853 Correlation Between PSA Levels and F-18 PSMA PET/CT Findings in Prostate Cancer Patient

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06209853
Status Recruiting
Phase
Sponsor Assiut University
Condition Prostatic Neoplasms
Study Type OBSERVATIONAL
Enrollment 59 participants
Start Date 2024-01-20
Primary Completion 2025-03-01

Eligibility & Interventions

Sex Male only
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL
Interventions
PSMA PET/CT

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 59 participants in total. It began in 2024-01-20 with a primary completion date of 2025-03-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

It is a cross sectional study aimed to correlate between PSA Levels and F-18 PSMA PET/CT Scan findings and to evaluate the impact of PET/CT findings on the patient management

Eligibility Criteria

Inclusion Criteria: * Male Patients with pathologically proven prostate cancer who will be referred to nuclear medicine unit to perform F18 PSMA for different indications Exclusion Criteria: * Undifferentiated prostate cancer. * Studies with motion artifacts, or those in which patient can't stay stable or calm during acquisition. * Severely ill patients that hinder imaging.

Contact & Investigator

Central Contact

Aalaa W Hussein, master

✉ aalaawhy@gmail.com

📞 +201092855007

Principal Investigator

Nadia M Moustafa, PhD degree

STUDY DIRECTOR

Assiut University

Frequently Asked Questions

Who can join the NCT06209853 clinical trial?

This trial is open to male participants only, studying Prostatic Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06209853 currently recruiting?

Yes, NCT06209853 is actively recruiting participants. Contact the research team at aalaawhy@gmail.com for enrollment information.

Where is the NCT06209853 trial being conducted?

This trial is being conducted at Asyut, Egypt.

Who is sponsoring the NCT06209853 clinical trial?

NCT06209853 is sponsored by Assiut University. The principal investigator is Nadia M Moustafa, PhD degree at Assiut University. The trial plans to enroll 59 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology